Nursing is the protection, promotion, and optimization of health and abilities, prevention of illness and injury, alleviation of suffering through the diagnosis and treatment of human response, and advocacy in the care of individuals, families, communities, and populations.

Drug Prices have been reduced up to 50 percent

Medicines that have been reduced due to the new Philippine drug act, just click the link

http://drugprices.wordpress.com/

Price cuts for 99 medicines Philippines

The five essential drugs under the MDRP are as follows: Amlodipine for hypertension; Atorvastatin for anti-cholesterol; Azithromycin as antibiotic/antibacterial; Cytarabine and Doxorubicin and all its salt form both for anti-neoplastics/anti-cancer.

There are additional 16 medicines dubbed as Government Mediated Access Price (GMAP) namely ; Telmisartan and Irbesartan for hypertension; Clopidorel for anti-thrombotic; Gliclazide for anti-diabetic/antihypoglycemic; Piperacillin plus Tazobactam and all its salt form; Metronidazole and all its salt form, Ciprofloxacin, Co-Amoxiclav (Amoxicillin plus Clavulanic acid) for antibiotic/antibacterial; Bieomycin and all its salt form, Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Mercaptopurine, Methotrexate and Mesna for anti-neoplastic.

Cabotaje said as high as 50 percent price reduction of these medicines could be availed of with the implementation of such order. She said drugstores are required to post in their respective establishments the list of medicines with their corresponding prices and dosages adding that they can go below the prescribed prices but not over.

According to a leading drugstore, aside from the 50 percent reduced price of Norvasc brand Amlodipine, a 20 percent discount could still be availed of if registered as Sulit Card member.

Some of the categorized drugs fall under anti-hypertensive, anti-cholesterol, anti-thrombotic, anti-diabetics, anti-biotics and anti-cancer drugs.

Eight pharmaceutical companies have agreed to also apply voluntary price reduction to 22 other molecules or 31 more products that were not in the MDRP list, bringing the total number to 38 drug molecules (or 72 products).

These medicines are indicated against hypertension, diabetes, influenza, hypercholesterolemia, cancer, arthritis, goiter, allergies and infections.


The list of the five medicines and their corresponding MDRP were:

ANTI-HYPERTENSIVE

Amlodipin 2.5 mg (P9.60); 5mg (P22.85); and 10mg (P38.50).

ANTI-CHOLESTEROL

Atorvastatin 10mg film-coated tablet (P34.45); 20mg film-coated (P39.13); 40mg film-coated (P50.50); 80mg film-coated (P50.63);

Amlodipine besilate 5mg + Atorvastatin calcium 10mg tablet (P45.75);

Amlodipine besilate 5mg + Atorvastatin calcium 20mg tablet (P66.25);

Amlodipine besilate 5mg + Atorvastatin calcium 40mg tablet (P84.42);

Amlodipine besilate 5mg + Atorvastatin calcium 80mg tablet (P89.99);

Amlodipine besilate 10mg + Atorvastatin calcium 10mg tablet (P51.13);

Amlodipine besilate 10mg + Atorvastatin calcium 20mg tablet (P73.25);

Amlodipine besilate 10mg + Atorvastatin calcium 40mg tablet (P91.79);

Amlodipine besilate 10mg + Atorvastatin calcium 80mg tablet (P91.79);

ANTIBIOTIC/ANTIBACTERIAL

Azithromycin and all its salt form:

250mg tablet (P108.50);

200mg/5ml powder for suspension (15ml), P427.50;

200mg/5ml powder for suspension (22.5ml), P638;

500mg tablet, P151.43;

500mg vial for injection, P992.50; and

2-gram granules, P468.

ANTI-NEOPLASTICS/ ANTI-CANCER

Cytarabine:

100mg/ml ampul/vial (IV/SC), P240;

100mg/ml ampul/vial (IV/SC) (5ml) or 500mg vial, P900;

100mg/ml ampul/vial (IV/SC) (10ml) or 1-gram vial, P1,800; and

20mg/ml (5ml) ampul/vial for injection, P1,980.

Doxorubicin and all its salt form:

10mg powder vial for injection, P1,465.75; and

50mg powder vial for injection, P2,265.74.

The ruling on the new rates will take effect on August 15. (PND)

See the complete list of the 5 above and the 22 others voluntary price reductions here
http://drugprices.wordpress.com/

http://www.allbusiness.com/medicine-health/diseases-disorders-cardiovascular/12595043-1.html

0 comments:

Post a Comment